Absence of hepatic enzyme induction in prostate cancer patients receiving 'Casodex' (bicalutamide)

Anti-Cancer Drugs

Volumn 7, Issue 1, 1996, Pages 54-59

  Kaisary, A ^a   Klarskov, P ^a   McKillop, D ^a  

^a ASTRAZENECA   (United Kingdom)

Author keywords

Advanced prostate cancer; Antipyrine; Bicalutamide; Hepatic enzyme induction

Indexed keywords

ANTIANDROGEN; BICALUTAMIDE; DRUG METABOLITE; LIVER ENZYME; PHENAZONE;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG BLOOD LEVEL; DRUG HALF LIFE; DRUG METABOLISM; DRUG SALIVA LEVEL; DRUG URINE LEVEL; ENZYME INDUCTION; HUMAN; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROSTATE CANCER;

EID: 0030043476     PISSN: 09594973     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001813-199601000-00006     Document Type: Article

References (0)